Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.78 HKD
Change Today +0.02 / 0.53%
Volume 420.0K
8049 On Other Exchanges
Symbol
Exchange
Hong Kong
As of 4:01 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

jilin province huinan-h (8049) Snapshot

Open
$3.80
Previous Close
$3.76
Day High
$3.81
Day Low
$3.73
52 Week High
04/9/15 - $5.20
52 Week Low
02/13/15 - $2.65
Market Cap
2.1B
Average Volume 10 Days
199.6K
EPS TTM
$0.24
Shares Outstanding
172.5M
EX-Date
10/10/12
P/E TM
12.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for JILIN PROVINCE HUINAN-H (8049)

Related News

No related news articles were found.

jilin province huinan-h (8049) Related Businessweek News

No Related Businessweek News Found

jilin province huinan-h (8049) Details

Jilin Province Huinan Changlong Bio-pharmacy Company Limited, together with its subsidiaries, primarily manufactures and distributes biochemical medicines under the Changlong and Shendi brand names in the People’s Republic of China. Its principal products cover inter alia antibiotics and medicines for the treatment of cerebral embolism, brain and heart blood vessels related diseases, hepatitis, diabetes, prostatic diseases, pain and bleeding caused by cancer and surgery, hormone disorder, inflammation of gallbladder, gallstones, and traumatic injury. It is also involved in the trading of biochemical medicines. The company, formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited, was founded in 1989 and is based in Mongkok, Hong Kong.

550 Employees
Last Reported Date: 03/31/15
Founded in 1989

jilin province huinan-h (8049) Top Compensated Officers

Executive Chairman, General Manager, Complian...
Total Annual Compensation: CNY473.0K
Chief Finance Officer and Executive Director
Total Annual Compensation: CNY219.0K
Chief Engineer and Executive Director
Total Annual Compensation: CNY274.0K
Deputy General Manager, Executive Director an...
Total Annual Compensation: CNY253.0K
Compensation as of Fiscal Year 2014.

jilin province huinan-h (8049) Key Developments

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended 31 March 2015

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. announced unaudited consolidated earnings results for the first quarter ended 31 March 2015. For the period, turnover was RMB 121,730,000, compared to RMB 107,729,000 for the last year. Profit from operations was RMB 17,391,000, compared to RMB 14,518,000 for the last year. Profit before taxation was RMB 17,316,000, compared to RMB 14,403,000 for the last year. Profit attributable to equity holders of the company was RMB 14,719,000 or 2.62 cents per basic share, compared to RMB 12,243,000 or 2.18 cents per basic share for the last year. Turnover increased for the first quarter of 2015 as compared with the same period last year mainly contributed by the increase in the sale of Hai Kun Shen Xi and Fu Fang Huo Nao Shu capsule.

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd., Annual General Meeting, Jun 25, 2015

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd., Annual General Meeting, Jun 25, 2015., at 10:00 China Standard Time. Location: t Economic Development Zone, Chaoyang Town,. Agenda: To approve the audited consolidated financial statements and the directors' report and the independent auditor 's report of the company for the year ended 31 December 2014; to approve the report of the supervisory committee of the company for the year ended 31 December 2014; to consider the reappointment of Reanda Lau & Au Yeung (HK) CPA Limited as auditors of the company for the year ending 31 December 2015 and authorize the directors to fix their remuneration; to approve the remuneration proposals for directors and supervisors of the company for the year ending 31 December 2015; to consider election of directors; and to give a general mandate to the directors to allot, issued and deal with Domestic Shares/H Shares not exceeding 20% of the aggregate nominal value of the Domestic Shares then in issue at the date of passing this resolution; and 20% of the aggregate nominal value of the H Shares then in issue at the date of passing this resolution, respectively 6.

Jilin Province Huinan Changlong Bio-Pharmacy Co. Ltd. Appoints Tian Jie and Qiu Fangping as an Independent Non-Executive Directors and Member of the Audit and Remuneration Committees

The board of directors of Jilin Province Huinan Changlong Bio-pharmacy Company Limited announced that on May 7, 2015, the Board considered and passed a resolution in relation to the proposed appointment of Ms. Tian Jie ("Ms. Tian") and Ms. Qiu Fangping ("Ms. Qiu") as an independent non-executive director of the Company and a member of the Audit and Remuneration Committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8049:HK $3.78 HKD +0.02

8049 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8049.
View Industry Companies
 

Industry Analysis

8049

Industry Average

Valuation 8049 Industry Range
Price/Earnings 12.5x
Price/Sales 2.8x
Price/Book 2.8x
Price/Cash Flow 12.5x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JILIN PROVINCE HUINAN-H, please visit www.jlchanglong.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.